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Abstract
T cell receptors (TCR) containing Vβ20-1 have been implicated in a wide range of T cell mediated disease and
allergic reactions, making it a target for understanding these. Mechanics of T cell receptors are largely unexplained
by static structures available from x-ray crystallographic studies. A small number of molecular dynamic simulations
have been conducted on TCR, however are currently lacking either portions of the receptor or explanations for
differences between binding and non-binding TCR recognition of respective peptide-HLA. We performed molecular
dynamic simulations of a TCR containing variable domain Vβ20-1, sequenced from drug responsive T cells. These
were initially from a patient showing maculopapular eruptions in response to the sulfanilamide-antibiotic
sulfamethoxazole (SMX). The CDR2β domain of this TCR was found to dock SMX with high affinity. Using this
compound as a perturbation, overall mechanisms involved in responses mediated by this receptor were explored,
showing a chemical action on the TCR free from HLA or peptide interaction. Our simulations show two completely
separate modes of binding cognate peptide-HLA complexes, with an increased affinity induced by SMX bound to the
Vβ20-1. Overall binding of the TCR is mediated through a primary recognition by either the variable β or α domain,
and a switch in recognition within these across TCR loops contacting the peptide and HLA occurs when SMX is
present in the CDR2β loop. Large binding affinity differences are induced by summed small amino acid changes
primarily by SMX modifying only three critical CDR2β loop amino acid positions. These residues, TYRβ57, ASPβ64,
and LYSβ65 initially hold hydrogen bonds from the CDR2β to adjacent CDR loops. Effects from SMX binding are
amplified and traverse longer distances through internal TCR hydrogen bonding networks, controlling the overall TCR
conformation. Thus, the CDR2β of Vβ20-1 acts as a ligand controlled switch affecting overall TCR binding affinity.
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Introduction
Research on T cell (TC) mediated adverse drug and
hypersensitivity to small molecule pharmaceuticals has
traditionally been focused on interactions with peptide-human
leukocyte antigen (pHLA) [1,2]. The TC receptor (TCR) is often
shown to be restricted to interactions involving recognition of
these molecules as presented in stable forms, such as
haptenized peptides, through complement determining region
(CDR) recognition of the stabilized molecule-pHLA [3]. Studies
of secondary interactions of these compounds with a TCR
alone is often complicated by the high level of variability found
in the CDR3 regions of the TCR, along with a large repertoire
of variable α/β domains expressed in any one individual [4].
Correlations in a number of pharmaceutical induced reactions
have been shown for specific TCR subsets [5-7]. These
neglected interactions are now receiving more focus, and
models developed on possible mechanisms of induced
hypersensitivity reactions caused through the TCR alone [8,9].
Our work focuses on a TC isolated from patients showing
maculopapular eruptions from Sulfamethoxazole (SMX), a
second resort antibiotic which has high incidents of adverse
drug reactions (ADR) and hypersensitivity [10-13]. Due to a
wide scope of already determined interactions with SMX
ranging from highly affine Ig, pHLA, haptenated serum proteins
and some suspected interactions with TCR alone, this
compound is ideal for probing most drug interactions. While a
number of small molecules show skewing towards various HLA
subtypes, such as β-lactam antibiotics or Abacavir, SMX shows
no such skewing. Other studies, such as those with
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Carbamazepine ADR show both skewing of HLA types in some
cases, or skewed TCR variable (V) domain (TCRV) α or β in
other studies and seem to be HLA dependent [14,15]. A
number of studies show other TCRV skewing in different
pathologies from allergy or drug induced allergy as well [7,16].
In our preliminary studies, a number of TCR from TC
responding to SMX, from SMX induced ADR patients had been
sequenced. From docking of SMX to models of these TCR
(Figure 1A), we found an interaction with one TCR subtype
containing Vβ20-1 and Vα17-1 which had no direct interaction
with the peptide or HLA interface.
Varied autoimmune pathologies have been associated with
TCR Vβ20-1 skewing as well as skin homing, suggesting some
indirect effect in pathology [17]. These analyzed pathologies
are primarily mucosa associated, and show a skewed TCR Vα
repertoire, Vα7-1 and 17-1 in particular, from TC isolated from
salivary glands in Sjögren’s syndrome. Other Vβ20-1
pathologies include chronic IgG mediated allergies,
Autoimmune Encephalomyelitis and other papular TC isolates
[6,16,18,19]. Additionally, in some cases Vβ20-1 containing TC
have also been implicated in tissue rejection, however these
remain controversial [20]. For all cases, these TC show a
limited degree of isolated natural peptide ligands all of which
are associated with basement membrane proteins [19,21,22].
In our case, lamaninα2 has been shown to be an associated
ligand, and is particular to overproduction in Sjögren’s
syndrome as an indicator of disease [23,24]. This would
suggest Vβ20-1 containing α/β TC might be a subset of TC
with a natural peptide ligand, or be associated with specific
tissues. Indeed, this has been recently shown for Vβ20-1 TCR
which were identified as skin homing or associated with nerve
tissue [17,19]. However in ADR and disease models, both
types of T cell mediated reactions are complicated by several
associational factors, such as HLA type, overproduction of a
particular protein, or in the case of Ig polyps or Sjögren’s
syndrome initial Ig mediated reactions and several other
immune cell types [18,24,25]. In all these cases, the chronic
inflammatory responses are eventually sustained through T
cells. With ADR, induced reactions mimic many disease
pathologies also found in autoimmune reactions [26,27].
Based on static models of TCR-pHLA from x-ray data, no
apparent effects are directly observable, which might indicate
this particular TCR subtype contains a molecule ligand-binding
motif or harbors a site that can interact with small molecules
free from the pHLA interface [17,28,29]. In addition, x-ray
models of TCR-pHLA interactions give conflicting modes of
binding and suggest no overall means for signaling in TCR
other than simple affinities associated with the protein-protein
interactions themselves [30,31]. This has as a consequence
led to two different theories of TCR mechanics in general,
related to overall conformational changes or simple affinity for a
particular peptide as the driving mechanism leading to TCR
induced signaling [32-34]. In the first theory, loops facing the
pHLA are slightly flexible, and recognition of the proper pHLA
alone induces larger TCR conformational changes which are
subsequently amplified through attached auxiliary cluster of
differentiation (CD) molecules [35,36]. In a second model, the
TCR is largely unchanging with a fixed HLA affinity respective
of variable domains used, and minor or no movement in the
TCR when engaging the pHLA. The hyper-variable CDR3α and
β loops, defining the unique amino acids on all TCR, then
recognize specific peptide amino acids presented by the HLA.
This model simply relies on kinetics related to the overall time a
TCR remains attached to the pHLA, working like a simple lock
and key. For T cell activation, a TCR-pHLA engagement period
beyond a determined time threshold is required to induce Ca2+
+ signaling. If the affinity of the TCR for the pHLA is met based
on either CDR3 loops additional hydrogen bonding added to an
already fixed variable domains unchanging affinity, Ca2++
signaling occurs. The large number of additional membrane
proteins associated with the entire process further complicates
either model.
How small molecules may elicit ADR in either case is often
focused on the pHLA based on either theory. In a model where
no conformational changes occur in the TCR, small molecules
themselves can only alter the overall affinity through binding to
the pHLA or TCR at the TCR-pHLA recognition interface, or
subsequent protein-protein interface. These would simply alter
the kinetics, driving them in one direction or the other and thus
altering the normal response. This does not negate other
interaction sites than pHLA, such as with the CD3 molecules,
where the actual sites of interaction are only partially
determined. If the TCR has larger conformational changes, a
small molecule itself may also cause associated ADR by
binding to sites on the TCR directly, not related to interactions
with CD molecules, or the pHLA. Structural studies remain
problematic in deciphering TCR induced drug allergies, or
mechanics, as themselves represent only super-cooled static
representations of single states. Molecular dynamics (MD) has
been used to further TCR-pHLA interaction models, however,
these have been limited by missing regions of the TCR, such
as the constant domains, or did not discern between
recognized or non-recognized peptides related to changes in
the TCR [37-39].
Here, we use MD of a complete extracellular TCR-pHLA in
solvent to explore the effects of a drug ligand already shown to
illicit a response in TC, at a molecular level (Figure 1B). Our
aim is to show an effect from SMX, and additionally to explore
the mechanisms of TCR recognition of the cognate pHLA. This
latter is one fundamental aspect often currently cited as a
reason TCR mediated ADR are not fully understood. In our
model, we focus on a site of small molecule interaction on the
TCR free from the pHLA interface. Additionally, we aim to
provide explanations of differences found in X-ray structures of
TCR-pHLA, applied to TCR binding mechanisms themselves.
This TCR was chosen based on the docking of SMX to a novel
site not characterized in previous studies found associated with
ADR or small molecule interactions. Some crystallographic
data exist showing this TCR to be the only interacting subtype
with toxic shock syndrome toxin 1 (TSST-1), also binding to the
same area as SMX on the TCR [40]. In most of these studies,
discrepancies in TCR variable domain nomenclature exist,
where Vβ20-1, using the IMGT nomenclature [41], is referred to
as Vβ2, Vβ2.1 or Vβ2s1.
Our simulations employ pulled force MD, a type of steered
MD, which allows for changes in free energy to be determined
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within short simulation times. This method also allows
conformational changes to be analyzed for proteins not
constrained, however the method always constrains one of the
proteins involved [37,42-44]. These simulations work by
applying an external energy that pulls the center of mass
(COM) of one molecule, here the TCR, away from the pHLA.
Figure 1.  Simulation Design.  A) Structure of Sulfamethoxazole, used in MD simulations. Green, methyl, yellow, sulfur, red,
oxygen, blue, nitrogen, white, other carbon and hydrogen. Aromatic carbon hydrogens are not shown. B) Schematic of the MD
simulation in initial and final state. ΔG for the reaction is simply the reverse of the simulation path, affinity is taken as the - ΔG. Box
represents entire unit cell without water, with Z axis as the long dimension, showing direction pull force was applied in the direction
of the arrow. SMX is shown as red stick modeled into CDR2β loop of the TCR in an initial docked, and final position after 4ns as
indicated by brackets, pHLA is lower fixed portion of model. The distance moved at the last frame is indicated with black bracket and
distance.
doi: 10.1371/journal.pone.0076211.g001
Sulfamethoxazole Induces a Switch in TCRVβ20-1
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e76211
This force is applied over a gradient during the simulation
process from 0 to the maximum required to move the TCR
away from the pHLA pre-defined by the user which may vary,
and is used directly to determine binding affinity between two
proteins or molecules. Simulations follow standards developed
for protein-ligand dynamics, which also include sampling space
over initial starting points defining a Gaussian distribution
around mean affinities [45]. These distributions reflect a more
realistic natural affinity, as at the molecular level free energy
becomes largely defined as a many-bodied summation
because of the overall effects of movement and introduced
randomized effects of all atoms contributing to calculations.
However, as an artificial force is used to speed up simulation
times from microseconds to nanoseconds, rate kinetics related
to association or dissociation times cannot be determined. This
leaves only total free energy, or binding affinity, as the
determinant kinetic parameter.
Results
Initial Model Generation
The model used in this study was originally developed based
on series of TC shown to give a proliferative response to SMX.
Models of whole TCR were generated using automated
modeling web servers as described in methods, as well as the
HLA-DRB10. For the Vβ20-1 TCR, several x-ray structures
exist which vary only for 4-5 residues at the CDR3 loop, and
equivalently the J segment. Inclusive of the x-ray structures for
HLA-DRB10 and the TCRVα, this allowed our initial model to
be based on 92-93% identical homology with solved structures.
For this study, an additional peptide ligand was determined
independently from published work, which would suggest
basement membrane ligands as possible peptide fragment
ligands. Here, Lamaninα2 was found as a high affinity ligand
from methodical docking as described, which showed some
correlation based on literature for this TCR subtype [23,24].
The entire model was initiated from a SMX bound conformation
found through extensive docking analysis, and two starting
points for simulations began with an SMX bound or removed
point, and were solvated as described (Figure 2). Simply
removing SMX, and allowing the TCR-pHLA to equilibrate at
300K in solvent without restraints changed the initial starting
conformation contacts between the two proteins. Normal TCR-
pHLA recognition occurs in ms to second time frames even for
non-recognized pHLA, thus such unrestrained equilibrations of
this model system allow TCR in both high or low affinity
recognition to be properly modeled as they would occur
naturally [38,45].
Based on these equilibrated models, differences were
already apparent based on the pHLA contact conformation
adopted during equilibration. These included differences
between primarily the CDR loops comprising the pHLA contact
interface, as seen in the initial frame of all supplemental
movies. Additional differences were apparent in the constant
domain as it was held, which differed by 5-7Å when
superimposed. In addition, the TCRVβ residues β220-230
which contact the J segment directly were held 1Å further away
from the J segment with respect to the entire 10 amino acid
domain. Overall, there was no apparent difference in hydrogen
bonding which would suggest one conformation was properly
recognizing the pHLA in a bound conformation. Initial starting
models contained roughly 25 for the SMX bound and 28 for the
non-bound pHLA interface hydrogen bonds. Based on these
models, MD simulations were conducted to discern between
differences in the overall pHLA binding process, which would
allow for SMX induced changes in one state from the other to
become clear.
For CDR2β representing the ligand binding site, initial
surface area and volumes were 29.552 (+/- 0.10) nm2, 5.76 (+/-
0.06) nm3, 28.59 (+/- 0.15) nm2 and 5.70 (+/- 0.07) nm3 for
SMX bound versus free. Using the TCR as whole, area and
volume differences were 240.452 (+/- 0.41) nm2, 76.54 (+/-
0.214) nm3, 247.44 (+/- 0.70) nm2 and 77.20 (+/- 0.192) nm3
with and without SMX. These are mainly in the solvent
accessible surface, however the binding site only represents
14% of this surface difference, while representing only 8-9% of
the total volume change observed in the TCR. From starting
models, it was apparent long range differences, or structural
changes must occur based on binding of SMX alone and these
differences are not simple volume changes from occupancy of
a particular site.
Total Energy Between Models
Total Gibbs free energy changes from SHAM calculated
means of the two composite simulations (Figure 3, Figure S1,
Movie S1, S2), showed a 7 fold increase in affinity from the
TCR alone to the TCR with SMX bound in the CDR2β. These
correspond to a change of 2 to 0.79 µmol affinity, that
represents a normal pHLA self interaction to an equivalent
weak natural killer T cell affinity for a responsive ligand. All
represented affinity changes are shown in reverse based on
pull simulation analytical methods, with higher energy
corresponding to a higher affinity. The pull force is used along
with the initial energies of the modeled system in the
computational mathematics to determine total energy change,
inclusive of solvent. This method however shows only total
energy change, and as a result, itself does not allow for energy
changes respective of a single domain, residue or subunit to be
determined. This analysis may therefore miss changes for a
particular component, such as a single loop or domain change,
and is used only to determine protein-protein or protein-ligand
binding affinities.
Individual Domain Energy Changes Between Models
Energy changes were extracted from each trajectory and
means calculated for domains making up the pHLA-TCR
recognition interface or self-interactions between the TCR.
Tabulated short range Coulomb and Leonard-Jones energies
between specific variable domain and pHLA, self-interactions,
but exclude solvation energies, which dominate the energy
landscape are shown (Figure 4A). Changes were apparent
from distant domains when SMX was present in the ligand-
binding site for respective domains. Overall these showed, for
summation of all shown variable domain energies, an
approximate 10 kcal/mol higher affinity with SMX, however
standard deviation overlaps significantly. For self-only
Sulfamethoxazole Induces a Switch in TCRVβ20-1
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interactions, the entire TCR was also analyzed for the same
energies, excluding pHLA interactions as well (Figure 4B).
These energies were truncated at interactions under 9Å in both
summations, and show changes for the TCR, which correlate
to functionality of domains. Contrasting this with total Gibbs
energies, varied components are assigned to asses where
particular energy contributions may arise, and to determine
energy landscapes that may be missed in total energy analysis.
This is highlighted for the TCR without SMX, which has a total
energy change of only 21 kcal/mol, however a large 156
kcal/mol energy change between a free and bound
conformation.
When only the CDR1-2α is analyzed, a higher positive
energy is demonstrated which disappears when integrated over
the entire TCR self-interactions. Standard error in this analysis
is large compared to total energy, as alignment of separate
trajectories is done by aligning individual energy summations
extracted from single trajectories without zero point
calculations. This analytical method therefore gives only rough
perspective on trends, such as individual domains overall
contribution to energy changes, without correlation coefficients
determined to lower overall standard deviations. These
rigorous calculations are done computationally using total
energy and the pull force used to disengage the TCR in
calculations with Gibbs free energy changes (Figure 3, Figure
S1C). Additionally, this does not discern, for the CDR1-2α, if
the energy difference observed is from pHLA contact or self
interactions resulting from the binding process.
Both CDR3 show a moderate change, with α being more
rigid as indicated by less fluctuation in the energy landscapes.
A negative energetic contribution is induced in the CDR3β
without SMX, however these fluctuate, also with SMX, indicting
the loop has some degree of movement even in the bound
state. This fluctuation is demonstrated through the standard
deviation in Figure 4. The CDR2β shows little difference, only
changing by 5-6 kcal/mol. Inclusive of standard deviations, the
two energy curves overlap significantly. The liganded form only
remains in a more rigid conformation than the free loop,
weather bound or free in solvent across the trajectories.
From extracted energy, the greatest difference occurs in the
CDR1 and 2α loop, with a 30 kcal/mol greater energy in the
absence of SMX. Correlation with the large increase in total
binding affinity does not correspond to any particular domain,
but indicates a greater energetic change between TCR
simulations in the CDRα and not the β domain. Comparison of
the CDR3 loops shows a slightly higher affinity in both α and β
for the SMX bound system, and no significant difference in the
CDR1-2β loop. Summation of the two CDR3 loop changes
Figure 2.  Models Used in Simulation.  A) Model used in MD simulation, TCR and pHLA shown 20 Å apart. HLA, red, TCR color-
coded according to domains used in analysis. Vα/β, variable domain α or β. SMX, stick model on CD2β, present in liganded
simulations. Peptide, yellow stick model as bound in HLA. Important TCR domains also have adjacent labels with same colors as
domain in model. Const., Constant domain shown as gold, β or grey, α. Colored bar in mid portion of TCR, aqua, CDR1-2α upper
connecting loop, orange, CDR1-2β upper connecting loop. TCR is oriented with β domain to right. B) Close up of CDR2β, with SMX
stick model as Docked. TCR is in bound position to the pHLA from starting models. Labeled residues form portion of hydrogen
bonding network affected by SMX and analyzed in detail, or directly hydrogen bonding to SMX. TCRVβ, green, TCRVα, blue.
doi: 10.1371/journal.pone.0076211.g002
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overcompensate, or equal if standard deviations are accounted
for, the difference observed in the CDR1-2α without SMX
bound. It would be expected from simple interference in static
hydrogen bonding induced in the TCR at the site of small
molecule occupancy the site on the CDR2β should show the
highest change. Energy means alone would indicate the
CDR2β binding site as a ligand binding site rather than working
by interference with the normal TCR pHLA hydrogen bonding.
Also from a direct observation of the primary model (Figure 2
A,B), the small molecule does not come into contact with the
pHLA in any direct way.
For the TCR as a whole, the energy change shows a large
energy barrier for the unbound SMX state, approximately 156
kcal/mol. Using either end of the simulation as reference, this
translates to roughly 132 kcal/mol in either the engagement or
disengagement process. In a forward or reverse state, this
would counter the favorability of either process. This energy
barrier is present when SMX is bound but much smaller,
suggesting larger conformational changes in the TCR without
SMX or separate states in the overall pHLA recognition
process. For the SMX bound conformation the energy barrier
has a peak of 185 kcal/mol versus a final energy of 117 kcal/
mol, giving a net change of 68 kcal/mol for the engagement of
the pHLA. Disengagement however would incorporate the
entire 185 kcal/mol making it much more energetically
unfavorable than binding. This indicates SMX is able to affect
an energy barrier present in TCR engagement of the pHLA,
however does not give direct insight into the conformational
change of the TCR. Summation of contributions between the
entire variable domain energies, inclusive of the pHLA
interactions, show these exceed the total energy changes. The
difference is partially explained by the energy barrier in TCR
only interactions observed, which includes a contribution from
variable domain interactions with the constant domain.
Additional long-range interactions, which have been shown in
other studies to also play a role in protein-ligand interactions,
Figure 3.  Total Free Energy Change.  Free energy calculated from all simulations. Grey bars, standard deviation, Means colored
lines, purple SMX, black without SMX, energy is in kcal/mol. Final SHAM calculated free energy changes are indicated on graph as
ΔG for the forward reaction, taken at 3.8 ns. The TCR in each simulation set becomes completely disengaged from the pHLA
between 3.2-3.4 ns, which is more apparent in simulation paths without SMX.
doi: 10.1371/journal.pone.0076211.g003
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Figure 4.  TCR and TCR Domain Energy Changes.  A) Free energy change for specific TCR loops and pHLA interactions are
given in kcal/mol. Graph title indicated TCR loop used from Figure 2A. Energies are Lenard-Jones and Coulomb short range
between self only and pHLA, excluding solvent effects and neighboring TCR domains. These are summed for all trajectories and
standard deviation represented by light colored bars, means as solid line. All energies, Y axis, are in kcal/mol. B) Free energy
change for whole TCR, using only short range Lenard-Jones and Coulomb interactions for self atoms, excluding all other energies.
These are summed for all trajectories and standard deviation represented by light colored bars, means as solid line. ΔE, total
energy change for forward reaction taken at 3.8 ns, min, highest peak energy change as max. In all graphs, simulations with SMX,
blue, without SMX, red. Short range cut offs in all were 9Å.
doi: 10.1371/journal.pone.0076211.g004
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are then also the remaining forces contributing to any energy
differences between analytical methods observed [46]. Overall,
these show that the majority of energy contributions to the
difference in SMX induced affinity change are through changes
within the TCR, rather than pHLA contacts.
Root Mean Square Differences Between Models
As a cross correlation to energy differences, and to check
other difference which may not have been apparent, both root
mean square fluctuation (RMSF) and deviation (RMSD) across
all trajectories were averaged. In both calculations a large
background was apparent, indicating some flexibility in all parts
of the TCR and differences associated with a random
placement of amino acid side chains, which becomes amplified
when averaging multiple trajectories [47]. An overall greater
background was shown without SMX for the TCR indicating a
less rigid molecule. Comparison of the RMSF, shown as a
composite structural image (Figure 5A,B), correlated with the
primary energetic observations. In the SMX bound structure,
much less movement was observed in the CDR2α. Primary
movements in this form were only at the distal ends of the
CDR1 and 2α loops facing the pHLA and the constant domain
of the TCR. Here, it was also observable that the inner CDR2α
has more movement, suggesting it is part of the pHLA
recognizing interface, which has been speculated from some x-
ray structural analysis [48]. Additional loss of flexibility was also
observed in the CDR3β which was not mirrored in the CDR3α
loop.
Two other notable differences were observed in the constant
domain of the TCR. One, a large movement in the constant
Figure 5.  Root Mean Square Changes.  A) SMX and B) no SMX RMSF displayed as B factors. C) and D) RMSD for respective
trajectories in A, and B. Residues are numbered for the α then β domains, background is higher for no SMX, indicating less fixed
side chains overall. Both truncate where STDV prevents differences from being observed. Linear distances are in nanometers in C,
D for the Y axis.
doi: 10.1371/journal.pone.0076211.g005
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domain helical region from residues α130-142 when SMX was
bound. The second was with the constant region residues
β220-230, which form a structure interacting with the βJ
segment of the TCR. This structure places a core TRPβ225 in
the center of a 10 amino acid loop, with a top distal ARGβ229
and is present in all TCR regardless of variable domains.
Mechanically, this structure holds the ARG at a position, which
intercalates between 2 adjacent residues in the J segment
based on backbone hydrogen bonding, and forces the
hydrophobic portion of the TRP in strongly rigid position against
2 residues of the J segment underneath the ARG site. This
forces them inward and allows linear force to be applied to the
J segment, itself, showing a role in maintaining the overall force
along the segment spanning from the CDR3β to the constant
domain in all TCR.
Comparing RMSD show an expected degree of correlation
with the RMSF (Figure 5C,D), and are used as a cross control
[49]. Differences are a greater degree of distance movements
in the α domain without SMX. In the presence of SMX, there is
almost a complete loss of movement in all three CD1-3α from
residues 1-100, but also much less movement with β loops.
Large changes begin at the distal end of the βJ segment at
residue 115, showing a greater movement in the constant
domain than in the absence of SMX. Additionally there is an
observable shift in residues close to the CDR3β loop, from the
distal end residues 94-98 to residues 85-90 and higher on the J
segment, when SMX is bound. Movement is also detected in
RMSD for the α domain, from residues 111 to 121, which
represent the end of the αJ segment, while the remainder of
movements are small but sharp along loop ends, or from the
constant domain above the top ends of the α/β loops in the
SMX bound TCR. This indicates a much more rigid TCR when
SMX is bound, along with a switch between primary recognition
of the peptide from the CDR3β to the CDR3α, and a change in
the constant domain in both the subunits.
Linear Movements Across Trajectories
We next analyzed direct movements between atom pairs and
COM for specific domains (Figure 6, Figure S2). Specific
positional differences for charged atom pairs could be
compared, with standard error ranging from 1 Å to 0.05 Å
(Table S1), based on overall movements of the loops indicated
along with the conformational flexibility of individual amino
acids used for the determinations. For the variable domains,
COM was determined by breaking regions into amino acids
sets representing various loops. Residue to COM definitions
were respectively, CDR2α residues 40 to 68, CDR3α residues
84 to 91, CDR2β residues 46 to 74, CDR3β residues 95 to 105.
COMs for the 2 CDR3 loops were only 2-3 Å apart, however
these COM coordinates did not change when more amino
acids were included as the loops are relatively linear, running
strait up and down from the constant domain direction to the
pHLA interface on one side, and slightly offset moving towards
the respective J segment.
Figure 6.  Distance Changes Between TCR Domains and Residues.  Positional changes between models. A) Individual residues
used in distance determinations shown across the entire trajectories. Each colored ball represents the labeled residue used B)
mean averaged distance change for all trajectories for COM defined in text (Figure S2) as CDR2α/β, CDR3α/β, or residues shown in
A). C) Residue pairs are indicated representing distances shown between two points in model, line colors correspond to graphs in
B), numbers at left correspond to graph numbers at upper right corner of each graph in B. SMX lines on left, no SMX, lines on right.
COM are graphs 1 and 2,each with 3 line comparisons. All single residues the remaining graphs. Line to number in C, last
compared residue on corresponding numbered graph in B.
doi: 10.1371/journal.pone.0076211.g006
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Comparisons of these movements for COM distances for
both trajectory sets from a pHLA bound to free showed the two
CDR3 loops did not move respective to each other. The
CDR3α and CDR2α only show a small 1Å difference, indicating
minor change when SMX is present, from a pHLA to free state.
This same movement is only half as large comparing the
CDR3β to CDR2α distances, only 0.5Å, with error estimates of
0.15Å. The largest change was from CDR2β to CDR3α COM, a
change of 3Å, which also indicates the CDR2β moves at an
angle rather than contracting as the CDR2α does. Correlating
with differences observed in RMSF or RMSD show a change in
the whole CDR2α when SMX is absent. This can also be
observed in the CDR2β and CDR3β COMs, which show a
change less than 1Å from the pHLA bound to free TCR state,
and the two extremities of CDR2 COM movements respective
of each other, of only 2Å.
When SMX is bound, this inter CDR2 movement is absent,
showing the CDR2β is more open. Overall COM movements
show a more rigid structure, held in a conformation that is 1-2 Å
more open, respective of the variable β domain. The variable α
domain retains a small degree of movement with ligand
present, however itself is also much more rigid. With the
CDR3α domain, as shown in graph 1 of Figure 6, between the
CDR2β, the largest observed movement is tied in with the
disengagement of the TCR when SMX is absent. Correlated
with the RMSD or RMSF, this attributes a portion of Figure 5B
and D to the disengagement process.
Analysis of movements between charged pairs were grouped
into upper and lower loops of the variable domains, and
constant domain atoms above loop ends at either variable
region. This latter was used to measure distances from either
the α or β variable domains in respect to the constant domain,
or respective variable domain loops and each individual
grouping is shown (Figure 6A). Distances are calculated as 6
sets, allowing the movement of loop ends to be shown with
respect to each other at bottom α/β, top α/β, and top α or β to
constant domain, represented as the mean across all
trajectories. Graphed distances (Figure 6B) are grouped
together based on scale or upward and downward movements.
The most notable effect from the presence of SMX was an
apparent inhibition of a fold of the top of the CDR2β downward,
which was fixed even after the TCR dissociated from the pHLA,
placing LYS63, ASP64 and LYS65 several Å further towards
the pHLA-TCR interface. These three residues have the
highest standard deviation, 1Å, as the terminal N or O were
used for distance measurements. This shows difference in
conformation, where LYS63 is moved pointing downward while
LYS65 only moves slightly adjacent in orientation.
Variable domain to constant domain movements, show a
switch between bound and unbound SMX. In the presence of
SMX, the tops of α loops move close to the constant domain
5-6Å, while in the absence the β loop tops move towards the
constant domain 3-4Å. This is a switch mechanism, however,
comparison of the top distal ends of all 3 loops from either
constant domain shows the movements are not entirely
grouped together. The loop spanning CDR1 to CDR2 moves
not only upward, α34 and β40 with or without SMX
respectively, but also towards the other respective variable
loops. This shows some sort of compacting of these loops
against the other respective domain variable loops. These
movements also carry some rotational aspect, as comparisons
in either case to the primary CDR3, J or CDR1 spanning loops
differ for residues α76 and α10 or β87 and β13, showing an
offset in direction along the outer variable domains. All
movements between loops either at the top or at bottom are
not uniform in respect to the same variable region, yet correlate
to movements from equivalent top to bottom.
Small differences in the two systems, exemplified from either
α19 and β51 or β26 of 2Å with or without SMX are translated to
much larger differences at the tops for the CDR2 or CDR1-2α/β
spanning loops of around 5-8Å. This shows the CDR1 to 2
movement is tied together, induced by engagement of the
pHLA. Minor differences respective to CDR3 loops, show the β
moving 2Å on pHLA recognition only with SMX, and the α fixed
this distance. This CDR3 movement is reversed without SMX,
and much larger movement is observed for the CDR3α than
the CDR3β equivalent with SMX. A small degree of random
fluctuation is also observed with the entire set of loops,
restricted to the distal ends of both the tops and bottoms as
shown by oscillatory movements of around 1-2Å. Together
these suggest a degree of randomized flexibility regardless of
ligand occupancy, but a much more rigid state of the TCRVα
with SMX.
Principal Component Analysis
We conducted principal component analysis (PCA) across
the first three primary vectors, with total energy projections
onto each of these averaged, for each trajectory set [43,50,51].
Means for all trajectories were calculated, and vector directions
as linear or rotational determined visually using filtered
trajectories for each principal component (PC) (Figure 7,8,
Movie S3-5). For individual linearized vectors, energy break
downs were 54.0 and 47.4%, 18.0 and 19.0% and 18.0 and
23.7% for PC1 to 3 respectively with and without SMX. A
switch in Z and X-Y plain movements, based on energy is
observed with PC2 and PC3, however vector numbering
remains the same to allow for direct comparisons between
PCA maps. Individual atoms and domains were pinpointed and
individual domains corresponding to the same residues for
COM calculations, with the additional grouping of residues α23
to 39 and β30 to 45 making up the upper inner loop between
CDR1 and 2 for each domain. This later grouping is based on
large movements not expected, but observed in linear and
RMSD or RMSF analysis.
Highest energy points from plots of PC1 and PC2, which
represent a rotational and stretching in the z direction, are for
the αJ segment in the presence of SMX. These shift to a more
even distribution between J segments incorporating the CDR3,
CDR2 loops, and a bias towards the CDR1-2β spanning loop in
the absence of SMX.
Projections along the PC3 and PC1 components however
show a much wider difference between SMX bound isoforms,
where the bias is more towards the CDR2 and 3α, with a minor
high energy peak along the CDR2β corresponding to contact
residues [43,51]. Along the PC2 and PC3 plots, energies
correspond to individual residues contacting the pHLA and
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residues, which form hydrogen bonds, or hydrophobic
interactions with the constant domain, directly from the α/β
domains of the TCR in the presence of SMX (Figure S3). With
SMX, a peak bias along this last projection is towards the β
CDR1-2 spanning loop, and a much larger overall contribution
from α constant domain residues. This further illustrates a
switch mechanism from β to α TCR domain movement.
A PCA for each domain retained the same directional bias
correlated with energy level for both the α/β CDR1-2
connecting loops and CDR2β only, showing these contribute
significantly to the total energy distribution and motion
associated with pHLA recognition. This additionally shows the
CDR2β as moving primarily in a rotational, rather than through
linear motion along with the other two upper loops. The upper
CDR1-2 spanning loops retain overall motions, and thus
energy contributions with or without SMX towards the
corresponding variable domains. These two loops switch from
upward and towards the other CDR tops to only towards the
other loop tops, β with SMX and α without respectively.
Figure 7.  Principal Component Analysis of TCR Disengagement Process.  PCA analysis of entire TCR. A-C) Principal motions
as defined by PCA and corresponding energy plots projected onto these for the first 3 primary vectors defined in top of graph as Y,
then X dimension indicated, scale is in nanometers. Top plots, with SMX, bottom plots without SMX. Heat maps are in kcal/mol.
Pinpointed domains or residues are shown in Figure S5. Highest energy peak for PC1 vs. PC2 is αJ loop with SMX, both loops
distribute this energy equally without SMX. Primary motion, vector 1, is a twist dominated by the constant domain in SMX and NO
SMX analysis.
doi: 10.1371/journal.pone.0076211.g007
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All other domains showed vectors moving along different
rotational or translational axis relative to their intrinsic motions.
All movements discerned from PCA and linearized analysis for
respective domains are illustrated as a composite image
(Figure 8A,B) in the presence and absence of SMX. Main
differences are complete switch in direction of the rotation of
the constant domain around a central axis through the TCR
towards the α domain when SMX is present, from a rotation
towards the β domain in the absence of a ligand. With α loops
a much larger movement upwards towards the constant
domain with SMX, when engaging the pHLA, is seen than with
the β without SMX.
A summary of these motions and associated energies
(Figure 8C,D,E, Figure S4), show each loop moving almost
independent of each other across trajectories, differing only in
domains based on the presence of SMX. One notable
movement, and corresponding energy difference, is highlighted
by the upper loop between the variable CDR2 to 3α. In the
presence of SMX, this loop moves inwards against adjacent α
domain loops and the constant domain, while lacking almost
completely any change without SMX. The lower portion of this
loop moves inward after disengagement of the pHLA when
SMX is bound, with only a more random fluctuating pattern
across the trajectory without SMX. A filtered set of trajectories
(Movie S6, S7) for the TCR as a whole highlight all these
movements. A final determination, resulting from PCA analysis
was an observation that the entropy of the two different TCR
conformers remained the same, approximately 5.6 kcal/mol,
allowing for a complete energy distribution to be calculated
(table 1) [52].
Pearson Correlation of Energy and Linear Movements
From PCA alone, large rotational energies dominated the
overall movements of the TCR, and motions related to the
constant and variable domains have not been described
previously. To further correlate motions determined for the TCR
and sub-domains, respective of constant domain positions,
Pearson’s r-value was used to check dependence of varied
distances (Figure 6, Table S2) against the first 3 PC vectors,
listed for bound SMX and the un-liganded TCR respectively
[53,54]. Additionally, we also determined these for the CDR2β,
as encompassing site of SMX induced switch in TCR affinity.
For the upper CDR1-2β, residues β40-β181 represent an
upward and twist motion with a change in r-values of 0.217 to
0.295 for PC1, -0.232 to -0.202 for PC2 and -0.421 to 0.206 for
PC3, thus main X-Y plain change dominates the energy
changes between the SMX to non-SMX state. For the
equivalent α loop, residues α34-β175, these correlations are
higher for rotational energy, but indicate a change in the
absence of SMX to primarily the X-Y plain. Equivalent r-values
were 0.790 to 0.795 for PC1, while stretching PC2 changed to
0.360 from 0.476, and -0.283 from 0.451 for PC3. Together
indicating a switch from X-Y, up and constant domain tilt, to a
rotational only movement in the presence of SMX.
Effects on the ligand binding domain, residues β65-β181,
were loss of rotation with SMX and switch to X-Y movement,
with r-values of 0.387 and 0.056 for PC3, while PC1 and PC2
showed correlations which switched to -0.365 from -0.871 and
-0.719 from -0.795 respectively. This showed an expected
correlation with respect to TCR affinity from the other analyzed
data, where rotation occurs from the variable β without SMX,
but also the X-Y plain change is significant. Analysis of all
positions shows inhomogeneous correlations to energy, which
mostly translate to relations between varied loops distal ends,
switching from β to α loops with SMX. This contrasts a domain
only analysis, showing small regions, or individual amino acids,
correlated more with X-Y plain and Z direction, which average
out between the variable domains for bound and unbound TCR
forms (Table S2).
TCR Hydrogen Bonding Changes on pHLA Recognition
Direct hydrogen bonding in analysis of protein energy
changes is often used as the most common proof or analytical
tool to show changes in static structures, such as x-ray, to
demonstrate differences between varied states [49]. To
analyze these same interactions comparative of the many
available pHLA-TCR structures, we used the first 300 frames
for each trajectory to determine fixed and oscillatory hydrogen
bonding with the pHLA, and internal TCR hydrogen bonding
thought to be relevant (Figure 9, Table S3). Respective of the
pHLA, a change from a total of 25 to 21 without and with bound
SMX occurs for the HLA, and 8 total in both for direct peptide
recognition. However, at any one time frame, only 12 with SMX
and 15 without for the TCR-pHLA, with 4 to 5 for peptide alone,
hydrogen bonds are present. This translates to a decrease of
2-3 hydrogen bonds when SMX is bound directly between the
TCR and pHLA averaged.
Hydrogen bonds between the TCR and peptide oscillate
between the indicated frames much less with SMX. Main
differences are with peptide ARG5 becoming fixed against the
CDR3β, and a change from backbone O or N recognition, to
direct amino acid recognition in the CDR1α with SERα21 and
ASNα23 to peptide ALA2 or THR3. The CDR1 and 3α loop
forms hydrogen bonds from ASNα87 and GLNα88 with HLA
GLUα53, GLNα55 and GLYα56, peptide ALA2, THR3 and
terminal NH3, that change to a recognition of these pHLA
residues from the CDR3α only when SMX is absent. This is
primarily through changes in CDR1α ASN23, SER21 and
THR20 moving more over the peptide. Larger changes seen
with the CDR2α and the HLA itself, are from TCR ARGα43 to
HLA GLNβ60, ASPβ62, LEUβ63 with, and TCR SERα44 and
ASNα45 to HLA GLNβ66 and ASPβ62 when SMX is absent.
Overall, recognition from the α domain for the entire pHLA
switches from CDR2 and 3 to CDR1 and stronger CDR3, when
SMX is bound.
From the CDR3β, a shift from slight recognition of the HLAβ
to α helix is apparent. The CDR2β retains the same amount of
hydrogen bonding with the HLA, 4 total, only changing overall
residues between the two proteins, which make up these
interactions. In the bound form, SER53 hydrogen bonds with
HLA LYS65α, switching from TCR LYS54 recognizing HLA
residues GLNα55 or ASNα60 without SMX. In both, induced
bonds oscillate, and are present only in 50% or less of bound
frames in trajectories. In the absence of SMX, there is a slight
shift of SER53 to ASN69, moving it away from the HLA, but
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Figure 8.  TCR Domain Motions from PCA.  A,B) Summary of principal motions for SMX and no SMX trajectories from PCA of
individual domains respectively. Colored arrows correspond to same colored loop, except black arrow in A, representing yellow loop
between CDR2α and 3α. Arrows are drawn against an X-Y-Z dimension, arrow heads point in direction of movement. C) CDR2β,
lower pink in A,B.D) CDR1-2α upper connecting loop, turquoise in A,B.E) CDR3α loop, salmon in models. Highlighted PCA for
individual domains in title of plot, V, vector used in Y and X axis, dimensions are in nanometers. Heat maps are in kcal/mol. SMX,
top plot, no SMX lower. These are used to illustrate the clearest differences. All individual domain PCA are shown in Figure S6. X
and Y dimensions are the same for each plot.
doi: 10.1371/journal.pone.0076211.g008
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also effects from the overall placement of the CDR2β over the
HLA.
Comparing TCR internal hydrogen bonds from self α/β loops
shows an increase of 5 and decrease of 5 for the α/β,
respectively with SMX. Our data shows that direct hydrogen
bonding with the pHLA from the TCR is not highly correlated
with the overall binding affinity, or energy changes observed
from the engagement process. More importantly, the mode of
binding seems to be tied in with TCR-pHLA affinity, and the
rigidity of the hydrogen bonds involved in a solvated system,
Table 1. Total free Energy, entropy and enthalpy calculated
for the TCR across all trajectories.
Energy Distribution ΔG ΔH -ΔS
SMX 139.77 +/- 15 134.15 +/- 15 -5.620 +/- 0.028
No SMX 23.79 +/- 5 18.122 +/- 5 -5.669 +/- 0.020
doi: 10.1371/journal.pone.0076211.t001
highlighted by the hydrogen bonds in peptide recognition. With
SMX present, the peptide amino acids recognized become
rigid, but also bonds from the variable α loops and the HLA
itself are important and more rigid. This is observed by duration
of the hydrogen bonds across the trajectory as the pHLA is
disengaged in Figure 9.
We visually inspected models to determine the network of
residue interactions affected by SMX binding, to determine how
these changes are transmitted (Figure S6, S7, Movie S8, S9).
In the absence of SMX, respective of the β domain, a small
network of hydrogen bonds is formed between primarily LYS65
and both SER82 and TYR91 or ARG36. Through ARG36,
SER88 and PRO39 bonding the inner CDR1-2 loop is pulled
close to the other β loops. This also allows for further hydrogen
bonding, between loop distal top ends, bonding with the
constant domain. A net result additionally holds the constant
domain fixed to the J segment from the functional domain
comprised of residues β220-230. These are all mediated
through adjacent loops affecting each other through cross loop
hydrogen bonding.
Figure 9.  Hydrogen Bonds.  Number of hydrogen bonds across entire trajectory, set at 3.5Å distance maximum, between the TCR
and pHLA. Trajectory 5, and Trajectory n5, for SMX (orange) and no SMX (blue) are graphed. Means are shown as solid lines, red
SMX, black, no SMX. Hydrogen bonds are release more rapidly without SMX, and are the same in all trajectories, with differences in
time frame at 20 picosecond intervals only over the first 2 nanoseconds for either trajectory set. This reflects bonds that change
randomly at the pHLA interface, even before the TCR disengages. All bonds found through the first 300 picoseconds are listed in
table S3.
doi: 10.1371/journal.pone.0076211.g009
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Bound SMX interacts directly with the backbone of LYS65,
and THR56, partially the side chain of ASP64, and with the
side chain of SER53, LYS63, LEU 67, ASN69 and TYR57. For
the latter there is a dependency of TYR57 (Figure 2B) in a
position found only in the unbound, respective of SMX, form of
the TCR, which switches to a stabilized bond with SMX and the
inner loop backbone atoms of the CDR2β. The residue ASP64
oscillates between a salt bridge with SMX sulfur, solvent or
adjacent backbone hydrogens. The main switch occurs through
this ASP residue, and LYS65 bending the loop forward.
Hydrogen bonding from LYS65 to SERβ82 and ASPβ87 which
disrupts the network with the inner CDR1-2 spanning loop,
causing the primary recognition and tilting of the overall
constant domain to occur. Additional effects from a re-arranged
hydrogen bonding network originating from this point also
cause the β220-230 to release the J segment.
Ramachandran Plots
Ramachandran plots for the residues making up the primary
switch (Figure 10, Figure S5) highlight the differences of these
residues in the SMX and non-liganded form of the TCR,
allowing another measure than those already employed to
illustrate these overall changes. Plots were generated for
residues around the SMX site thought to be involved. In all,
most of the same residues found in hydrogen bonding with
SMX also show shifts in angles around the amino acid side
chains.
Hydrogen bonding, or large linear differences in position of
an amino acid can sometimes not change the angles found,
which is reflected only in 1 residue plotted, ARGβ36. This
residue is 3Å displaced between structures with and without
SMX, however this does not show in Ramachandran analysis.
For TYRβ57, the structure is fixed with SMX in a position only
observed in the unbound TCR without SMX. From direct
analysis this is not apparent, only after observing visual
trajectories can this be seen. For LYS65β this is also an effect
even though angles are slightly altered, while LYSβ63 and
ASPβ64 show a significant change between conformations. For
LYS65β, the observed difference is reflective of randomized
changing bonds, while SMX is present primarily between
SERβ82 and ASP87, while this residue is hydrogen bonded
between SERβ82 and TYRβ91 or ARGβ36 without SMX. This
randomized movement is not significantly reflected in the
overall plot, however small changes are observable between
the two conformations.
Discussion
Work here focused on a TCR isolated from a pool of TC
showing a proliferative response to SMX. These were originally
isolated from whole blood mononeucleocytes from a patient
showing skin eruptions when administered SMX. The aim of
this work focused on non-covalent interactions with the TCR,
as related to ADR, and the TCR was selected based on having
no clear direct interaction of the small molecule with the pHLA
interface [8,12,55]. Our goal was not to define the actual culprit
for the particular patient, which may include several other
factors giving rise to ADR. Rather we wished to utilize the
Figure 10.  Ramachandran Plots.  Ramachandran plot of 4 primary residues on CDR2β affected by SMX binding in loop. Plots are
for entire trajectory, and show also differences in bound TCR to free TCR. Φ and ψ angles are labeled, axis are from -180 to 180
degrees. Top are with SMX, bottom without. Intensity, right color scale, indicates scaled intensity factor relating percent occupancy
across all trajectories, red, highest occupancy scaled to number indicated. All data in each plot represent 100% of angle occupancy
summed from all trajectories in set.
doi: 10.1371/journal.pone.0076211.g010
Sulfamethoxazole Induces a Switch in TCRVβ20-1
PLOS ONE | www.plosone.org 15 October 2013 | Volume 8 | Issue 10 | e76211
highly reactive small molecule SMX as a probe to characterize
specific interactions with TCR not completely explained from
other studies. This particular TCR type, and identified
interaction should prove useful to ADR research, and the
immunological community as a whole, providing direct
characterization of a small molecule interaction that can elicit a
change in the TCR-pHLA mechanics. While this may not be the
cause of the reaction in the original patient, the particular
Vβ20-1 has been associated with a range of autoimmune
diseases, also having unique features such as being the only
TCR to bind TSST-1.
As ADR themselves mimic autoimmune disease to a high
degree, it makes this particular TCR a valid target for
characterization related to either type of medical problem
[9,26,27]. Like autoimmune disease, different ADR may also
have a more complicated nature for onset. This is highlighted
through comparisons of such diseases as Sjögren’s syndrome
and papular skin eruptions, and drug induced eruptions on lips
of patients that has been shown to occur [17,23-25]. Our model
determined Lamininα2 as a highly affine ligand for the TCR
used, a protein often associated as over-expressed in salivary
glands of Sjögren’s patients. Nevertheless, like this
autoimmune disorder, several other factors such as tissue
damage through other means, and several other effector
immune cells make direct cause and effect analysis of these
models difficult. It may be these TC containing this TCR are
only part of the overall causative mechanism behind the
pathology. However ADR has been shown to mimic
inflammatory response at several levels including cytokine
profiles produced by associated effector cells involved, with TC
isolates present in all cases. A further example of complexity,
in the case of Sjögren’s syndrome the onset was shown to be
caused through initial Ig production against a Rho-GTPase,
initial tissue damage, and accumulation of nucleotides. The TC
containing Vβ20-1 are secondary, however are always found
as salivary infiltrates and have been shown to sustain the
inflammatory response [6,16,24]. In this entire scheme, even
further complexity is observed with patients often showing an
overproduction of Lamininα2, a basement membrane protein
expressed at nerve tissue, some basement membrane, and
salivary gland sites.
Further hindrance in defining overall molecular aspects of
ADR arise from lack of a direct understanding of TCR
mechanics in the entire process. Currently conflicting results
exist on what constitutes differences between signaling and
non-signaling TCR based on structural studies [4,32,36,39,56].
Related to ADR or autoimmune disease, these have focused
on the pHLA interactions themselves, and largely neglected
TCR conformations, primarily as HLA types vary between
individuals, while TCR subtypes do not [1,10,14]. These
differences are highlighted in reviews analyzing dozens of
pHLA bound TCR which show TCR orientation over the pHLA
that differ drastically in placement of all CDR loops. There are
also no structures available that indicate any interactions
outside of the pHLA would cause effects on the TCR mode of
antigen recognition. A secondary result of our work here
compares two pHLA recognition events, where the peptide and
HLA do not vary, only the TCR conformation. This allows a
unique view of changes that occur in the pHLA recognition
process, which can be directly related to the ample structures
available. These changes are described in detail, related to this
particular TCR, and are based on SMX induced changes.
While this constitutes a perturbation in the normal system
different from the processes as they are usually described it
may be a restricted case. Regardless, this can also provide a
framework for already available data to describe and alleviate
discrepancies from multiple conflicting results in immunology
related to this process.
Our data shows for the particular TCR analyzed two
completely different modes of pHLA recognition. This
encompasses primary recognition and alignment of the whole
TCR via intrinsic constant CDR1αβ and CDR2αβ domains over
the HLA. In a normal mode, once recognized, the Vβ20-1
domain then relaxes, and the CDR1β and 2β move 1 to 1.5Å
away from the variable domain COM, primarily the CDR3α/β
loops mid region. By doing this, a few amino acid side chains in
the CDR3β terminal portion are given wider degrees of
movement, which allow recognition of the presented peptide.
This small domain movement also allows the CDR1β and 2β to
recognize the HLA better, forming hydrogen bonds with
residues on the HLA α helices. Upper portions of the CDR1
and CDR2β form direct hydrogen bonds with residues starting
from LYSβ65, 63 and ASPβ64 that signal along a network
across the upper edges of the Vβ domain of the TCR. These
culminate in hydrogen bonds with the constant domain, also
mediated by bringing the inner CDR1-2 spanning loop closer to
the other Vβ loops. This tilts the constant domain to the Vβ
domain.
With SMX bound in the CDR2β, hydrogen bonding translated
to upper portions of the α domain changes equivalent hydrogen
bonding on one side of the TCR, moving similar amino acids
above the CD1α and CD2α loops 5Å closer, effectively tilting
the entire TCR constant portion to one side along an axis
between the two variable domains, now toward the Vα. This is
accomplished also by releasing the domain comprised of
residues β220-230 from the βJ segment, which is held in place
normally. The two J segment differences are reflected in the
PCA analysis, which shows a switch to the αJ segment as the
highest energy peak in PC1 vs. PC2 energy plots.
On TCR comprised of Vβ20-1, a pocket exists in the CDR2β,
which has a strong affinity for SMX. This pocket has only in
prior studies been shown to bind TSST-1, acting as a
superantigen by TCR-HLA cross-linking outside the peptide
groove [40]. The highlighted variable α/β switch in recognition
and tilting of constant domain is controlled through this pocket.
In the presence of bound SMX, 2 amino acids at the top of
CDR2β, LYSβ65 and ASPβ64, form alternate hydrogen bonds
with the inner CDR1-2β loop. Additionally, TYRβ57 is held
away from adjacent CDRβ loops. Residues in all these loops
then also switch to higher residues in the adjacent CDR3β and
J segment, or constant domain. A rather large CDR2β terminal
portion is also prevented from holding CDR3α with SMX bound,
allowing the loop to move closer against other CDRα loops
before pHLA recognition. In this SMX bound conformation, the
TCR Vα domain then forms hydrogen bonding with the TCR
invariant constant domain, and the CDR1α and 2α loops dilate
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from the CDR3α as with the β loops of un-liganded TCR
recognition. These dilations however are only in the distal ends
of these loops, while the central portions remain closer
together. In a similar fashion, the CDR3α terminal residues
then recognize the peptide more specifically than in the normal
recognition mode, and an overall switch from CDR2α and 3α,
to CDR1α and 3α recognition occurs. Net effects are a 7 fold
increase in binding affinity for the same peptide and HLA in the
presence of ligand.
Implications for the mechanics of TCR recognition from this
data show the hydrogen bonding with the pHLA is not directly
determinant of the affinity [31,56,57]. It is demonstrated the
mode of binding by a TCR is more important for the affinity, as
the hydrogen bonding with SMX has a net loss of 3 hydrogen
bonds however has a much higher affinity for the same pHLA.
The change of tilt for the constant portion of the TCR, in
respect to the variable domains, indicates a possible “on” or
“off” mechanism for TCR signaling. Published x-ray structures
for whole TCR-CD4-pHLA complex show docking of the Ca2++
inducing signaling CD3εγδ portion of the entire macromolecular
signaling complex to the β domain only [58,59]. This would
indicate TCR signaling is not directly affinity based, rather
conformational based and the way the Vα or Vβ primary
recognition of the pHLA occurs would dictate signaling through
tilting of the constant domain. Our case however may be
specific for the TCR used in the MD experiments, and without
definitive proof of the properly bound CD3εγδζζ/TCR complex,
this is still speculative. As this TCR was isolated from TC
proliferating when SMX is present, but failing to proliferate
when not with the same antigen presenting cells this remains
likely however. This is furthered, as most isolated T cells do not
respond to SMX in proliferation assays [11,55].
We also show that the affinity change is not dominated in this
case by global loss of movements induced in the TCR, by
comparing entropy and total affinity changes across the
trajectories. Entropy remains the same in both TCR
conformations in our MD simulations (Table 1), showing solute
effects are roughly equal, thus enthalpy dominates the affinity
change observed [32,60,61]. In individual domains and whole
TCR energy summations, the difference is explained by the
non-SMX bound TCR having an energy barrier equal to the
positive change in energy, thus canceling any effects through
conformational changes on pHLA recognition. These motions
are exemplified for both TCR forms by large rapid change on
pHLA disengagement (Figure 6), such as between the CDR3α
to CDR2β loop, larger constant domain tilt with SMX (Table S2,
Movies S6-S9), and large but continuous random movements
in the α loops overall without SMX (Figure 5). Comparatively
the changes in motion between TCR with and without SMX are
only different domains, loops or J segments but remain equal in
respect to motion alone. For the SMX bound TCR, these
energies do not include a large negative energy barrier, and
thus the recognition process retains a large positive
contribution from the TCR conformational changes.
In conclusion, for our specific TCR comprised of Vβ20-1 and
Vα17-1, a clear switch in mode of binding is demonstrated
when a proper ligand, here SMX, occupies a large CDR2β
pocket. This may imply a natural ligand exists, however can
also simply be an artifact of interaction with SMX. We also
show affinity change is not straight forward and based on
differences in pHLA hydrogen bonding alone, rather it includes
a complex system of hydrogen bonding internal to the
conformation of the TCR as it is held in a pHLA bound state.
This is shown as the majority of energy associated with TCR-
pHLA interaction is dominated by energy internal to the TCR
and not pHLA interactions (Figure 4). Pearson’s correlations of
energy and movements show the larger domain tilt as
dominant, with varied contributions from loop ends themselves
only switching between variable domains in the presence of
SMX. This would indicate a signal to cause domain tilting, and
the tilt of the domain to the α or β variable side is the dominant
feature in this TCR related to affinity (Figures 7, 8). Overall, our
data shows this particular TCR can undergo large conformation
shifts, suggesting competing hypothesis need to be validated
with other models. One, specific differences between TCR
subtypes not related to variable CDR3 loops play roles in pHLA
recognition, or second that generally TCR themselves do utilize
larger conformational changes in their overall pHLA recognition
process distinguishing a signaling or non-signaling
conformation. Our model described here fits this second
hypothesis accurately, but cannot exclude unique features of
this TCR without additional simulations utilizing completely
different TCR subtypes. For this particular TCR, SMX is clearly
shown to cause a change in TCR conformation and pHLA
affinity, thus indicating TCR containing Vβ20-1 have a roll in
drug allergy.
Materials and Methods
Initial Model Generation
Models were generated using Swiss-modeller [62] from the
sequenced TCR α,
QQGEEDPQALSIQEGENATMNCSYKTSINNLQWYRQNSGR
GLVHLILIRSNEREKHSGRLRVTLDTSKKSSSLLITASRAADTA
SYFCATDGNQFYFGTGTSLTVIP and β
GAVVSQHPSRVICKSGTSVKIECRSLDFQATTMFWYRQFPK
QSLMLMATSNEGSKATYEQGVEKDKFLINHASLTLSTLTVTS
AHPEDSSFYICSARGQGENVYGYTFGSGTRLTVV, alignment
against the model PDB 2IJ0 [40], and the deposited HLA
classII, DRB10 sequence UniProtKB Q30167 [63]. The final
model was then created by superposition of the TCR, TCRβ
from residues 0 to 244 and the TCRα residues 1 to 190, onto
the HLA peptide, truncated at the first residue on the
extracellular membrane side, by root mean square alignment to
model PDB ID 1FYT [64]. The SMX structure was generated
using chemsketch [65], converted to PDB format with
openbabel and docked into the TCR using Autodock and
Autodock Vina [66,67], showing a strong affinity at a site in the
CDR2β in prior computational studies. This initial docking study
utilized 60 rigid and 60 flexible global dockings of SMX against
multiple models of TCR, and a TCR containing Vβ20-1 chosen
because of an SMX docked site free of the pHLA interface.
Each TCR model was prior to docking energy minimized, and
equilibrated in SPC water at 300K. For the TCR used here, a
refined set of 60 flexible docking runs were conducted where
amino acids defining the CDR2β, res 54-71, were allowed
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movement. For these the docking site was limited to the
CDR2β loop dimensions. The highest affinity docked
conformation of SMX was then used in initial SMX bound
models. The program PRODGR was initially used to generate
an all atom topology for the SMX molecule [68], and minor
changes to the charge set corrected from the IUPAC standards
(www.IUPAC.org). This topology was used in all simulations.
Peptide Ligand Determination
Energy minimization of the initial structure from Swiss-
modeller was done in Gromacs [69], using only SPC water and
a 53a6 force field [70] at a temperature of 300K. After several
preliminary large scale screening processes, a working
computational method was developed to screen small peptide
fragments. From this, a 15 amino acid peptide sequence,
GATGRKCDGCKHWHA corresponding to human Lamininα2,
was determined using a modified AutoGrow [71] script (http://
sourceforge.net/p/autmatedpeptide) to generate random
peptide fragments, and docking these using Autodock Vina
[66], to the TCR-HLA structure. A complete screening method
was to define two separate docking areas beneath the CDR3
loops and encompassing half the HLA peptide binding pocket.
These areas overlap for 4-5Å to accommodate a single end
amino acid in any resulting peptides between docking sites,
which lie on top of each other in the mid portion of the HLA
peptide groove. Either defined area was large enough to allow
4-5 linear amino acids to fit within the dimensions based on
initial starting TCR-HLA models. Software was then given a
linear 4-5 amino acid peptide, and allowed to mutate these to
form a library of non-redundant peptide fragments. Both CDR3
loops were allowed complete amino acid flexibility, including
the backbone bonds, and each defined area docked in
separate batch runs. A series of 5 runs, per 10 cycles, at 100
screened mutations per cycle allowed for the determination of a
high affinity set of 2-3 ligands from either defined area.
Approximately 7500 fragments were screened in this way.
From these, several 7-8 amino acid chimeras were produced
from overlapped amino acids at the HLA mid groove portion
and protein-blast (NCBI/NIH ref) used to determine the
suspected proteins used as a self-ligand. Using the protein
sequences retrieved, peptides of 9-15 amino acids were
chosen based on sequence alignments over the HLA binding
groove and the docked small fragments corresponding to the
identified proteins. These resulting peptides were docked into
the whole structure using Autodock Vina, retained flexibility in
the CDR3 loops, and allowing half of the ratable backbone
bonds of the peptide to rotate. Starting at 8 amino acid
fragments and moving to 15 amino fragments, 1 residue was
added for each generated peptide based on the identified
protein amino sequence, giving 8 different length proteins
overall. Allowing all peptide backbone bonds to rotate
prevented any docked conformations to be determined, often
resulting in circular or globular peptide orientations. Repeated
docking is necessary for each defined larger peptide fragment,
as the conformational space for each ligand increases with size
of the peptide, and at least a dozen docking runs conducted
per peptide needed to compare fragments. Affinity based on
averaging all docking runs individual calculated affinities was
used to determine the final best ligand.
Initial Molecular Dynamic Model Equilibration
From the complete structure with bound peptide, solvation
with SPC H2O, NaCl, and KCl at 0.15 and 0.08 M, pH 7.4
through amino protination state, were performed in Gromacs
using the 53a6 Gromos force field, and equilibrated over
several ns at 300K temperature, 1ATM pressure using a Nose-
Hoover thermostat [72,73] and Parrinello-Rahman pressure
coupling. Initial MD simulations were set using a TCR with
bound, and unbound SMX. For both of these, solvent was
40,000 SPC water, 48 K+, 129 Na+, and 177 Cl- atoms, in a
simulation box of 90.122, 164.222 and 90.122 Å. A 4 ns,
unconstrained MD for the SMX, or non-SMX simulations were
then conducted, and initial structures taken every 364 ps for
production run pulled simulations.
Production Run MD Simulations
Initial steered molecular dynamics were then set as 11 with
SMX and 10 without SMX pull simulations using starting
structures spaced as described from the un-restrained 4 ns
simulation as starting points, and a modified protocol for TCR-
pHLA free energy calculations described previously [37]. Pull
force was set as a range for each run from start 0 to finish 2000
kJ/mol*nm2, as determined maximal force for the TCR with
SMX found in trial runs, to completely separate the TCR from
the pHLA. Pull force ranges were kept constant for without
SMX simulations to reduce overall error estimates in energy
comparisons between the two sets of trajectories. This force
was applied harmonically in increments to the COM of the TCR
in both simulation sets, along the Z axis of the simulation
(Figure 1). A pull distance was set at 0.0005 nm/ps, for a total
of 4ns each simulation along the Z axis. In each simulation, the
pHLA was positionally restrained. Bond constraints were kept
constant using LINCS. A distance of 20 Å was achieved for
each simulation between the TCR and pHLA, with a mean
complete separation time of all long range interactions between
the TCR and pHLA at 3.2 ns. Center of mass, and rotational
effects were removed from overall simulations by linear
correlation COM removal set in the initial parameters for the
entire system every 2 fs intervals, and 300K temperature,
1ATM pressure kept constant using a Nose-Hoover thermostat
and Parrinello-Rahman pressure coupling. All short-range
interactions were truncated at 9Å, temperature coupling
conducted at 0.1 ps, and pressure coupling at 1 ps. Wall forces
were not used as described in the published protocol, as box
size was increased in the X and Y dimensions.
Data Analysis
Analysis was performed using Gromacs, and auxiliary
software from numpy [74], Pymol (© Pymol Mol.Graphics
Schrödinger, LLC) and VMD [75], linux gnumeric (GPL license)
and qtiplot/SciDavis. For analysis, statistics were determined
from total energies taken at 2ps frames for total ΔG [76] using
pull force, and 20ps frames for all other energy calculations. All
trajectories were treated as separate, and averaged for
particular data involved respective of the two separate sets of
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simulations. Fitting of structures was to initial starting structures
for the respective trajectory, and either Cα or all atoms used as
indicated. RMSD and RMSF were calculated in gromacs [47]
using internal tools, using all atoms. PCA and covariance
[43,77] were calculated from raw trajectories and energy files
using g_anaeig and g_covar tools in Gromacs against each
trajectories starting model, converted to matrices using a set of
matrix manipulation scripts written in numpy, and averaged in
qtiplot/SciDavis for figures to represent mean distributions of
energies. Figures were generated in qtiplot/SciDavis.
Analysis of short-range interactions (Figure 4) were
conducted in two parts. For specific variable domains, all
Leonard-Jones and Coulomb short-range interactions were
summed for self and pHLA at a 9 Å cut off. All interactions with
neighboring domains, or solvent were excluded. Self-
interactions were defined as atom-atom interactions within the
defined index groups, excluding other TCR atoms. Index
groups analyzed were all atoms respectively in residues
α40-69, CDR1-2α, α84-94, CDR3α, β46-76, CDR1-2β, and
β94-106, CDR3β (Figure 4A). For the whole TCR (Figure 4B),
all atoms within the TCR were included, and all other atoms in
the model including pHLA were excluded. Energies were
extracted from energy files, and zeroed by hand for each
trajectory. These were then aligned and standard deviation and
means across all runs calculated using qtiplot/SciDavis.
For PCA positional mapping, the initial structure using all
TCR or TCR domain atoms for each trajectory was projected
onto the corresponding vectors, and positions determined for
each atom on the plot as X an Y ordinates by hand. An
additional set of indexed atoms included α25-39, CDR1-2α
bridge and β32-45, CDR1-2β bridge. PCA filtered trajectories
were visually inspected in VMD and pymol rendered movies to
determine vector direction. Additional filtered trajectories using
gromacs tools g_filter to remove random fluctuations and used
for movie S6, S7 with filter set at 3. Hydrogen bonding was
determined in gromacs. Distances were determined in gromacs
using built in software analytical tools for individual trajectories,
and average and error estimates calculated in qtiplot/SciDavis.
Pearson’s linear correlation values were calculated in gnumeric
using each vector mean against distance mean. All other
analysis was conducted using Gromacs internal scripts,
internal software analytical tools, or software stated in
combination. The initial Gromacs used was 4.5.2 for all
simulations, however 4.5.5 was used for analysis.
Supporting Information
Figure S1.  Free Energy Changes of Simulations. Free
energy change for individual trajectories A) with SMX, B)
without SMX. In A,B trajectory number indicates time point from
initial run taken evenly spaced as indicated in methods. C)
Wham analysis of same trajectories as shown in Figure 3, for
comparison. These incorporate autocorrelation functions, and
bootstrap analysis. The original experimental design
incorporated a lambda value but was not used in single
histogram analysis shown in Figure 3.
(TIFF)
Figure S2.  Center of Mass Definitions. Center of mass
(COM) shown in Figure 4. Centers are colored balls, CDR2β,
blue, CDR3β, pink, CDR3α yellow (hidden under loop), and
CDR2α light blue. Lines are 6 different measured distances
shown in graphs 1 and 2, from Figure 6 B. Centers were drawn
as close as possible to calculated COM, using pymol, and the
closest atoms to the calculated point. These may be off by 1-2
Å, and are for reference to Figure 6 only.
(TIFF)
Figure S3.  Positionally Mapped Domains and Residues. A)
Thick lines purple Jβ, blue Jα. These are more equally
distributed without SMX. Thin lines, red, CDR1-2α loops, black,
CDR3α, green, CDR1-2β loops, orange, CDR3β, pink,
CDR1-2α spanning loop, maroon, CDR1-2β spanning loop. B)
With SMX 1, CD1-2α spanning loop, 2, Top CDR1α, 3,
CDR3α, 4, CDR3α peptide contact, 5, Constant β, 6, Constant
α, 7, CDR2-3α spanning loop, 8, CDR2β bottom, 9, CDR1α
bottom, 10, Constant β domain, 11, Constant α to Jα contact,
12, ASP64β, 13, LYS 65β, 14, CD2β bottom, 15, CDR1-2α
spanning loop. Without SMX 1, CDR1-2α spanning loop, 2,
CDR3α, 3, CDR1β to Jβ interaction, 4,5, CDR3β, 6, Constant
β, 7, CDR2-3α spanning loop, 8, Constant α, 9, Constant β, 10,
Jβ, 11, CDR2β bottom, 12, CDR1α bottom, 13, CDR1α mid,
14, CDR1α upper loop, 15, CDR2-3β spanning loop, 16, Jα, 17
CDR2β. C) Peaks are residue specific. Without SMX a 15
amino acid loop spanning the constant domain from the β to α
is stopped by CDRβ loops forcing VALα143 inward through
hydrophobic interactions. With SMX a spring like movement to
the top of the α loops results in PHEα158 moving. In figure CD
refers to CDR loop.
(TIFF)
Figure S4.  Remaining Sets of PCA Analyzed for TCR
Domain Energy and Motion Determination. Remainder of all
energy projections from PCA analysis for varied domains
analyzed on the TCR. A summary of the principal motions
corresponding to these first 3 vectors is shown in Figure 8, A)
and B) for SMX and no SMX models. All PC vs PC, indicated
on axis, are shown as with, and without SMX directly below.
Energy changes can be correlated to principal motions,
however only those indicated in the paper text are in the same
directions, regarding vector motions, indicated in Figure 7. Note
energy levels also vary for some heat maps shown
significantly. This is highlighted by CDR3β, which also shows a
larger degree of scattered low energies as a result.
(TIFF)
Figure S5.  Additional Ramachandran Plots. Ramachandran
plots of other residues in the hydrogen bonding network
affected by SMX indirectly. These show several features; For
ARG 36 on the CDR1-2β spanning loop, the only observable
difference is a very small increase in degree of movement
around a set angle, even though the residue moves 3-4 Å in
the bound SMX Vs. unbound simulations. Residue GLU 62
however represents a change between bound TCR with or
without SMX, while the free TCR in either is the same. GLU86
and ASP 87 both show complete conformational changes of
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the residue positions throughout the trajectories between the
two simulations, with a minor degree of overlap. Together
these show that Ramachandran angle analysis can highlight
residue changes, however a structural difference may be
missed if the angles are the same, even if the residues overall
position is significantly different. Intensity, right color graph,
indicates percent occupancy across all trajectories. Top plot,
with SMX, bottom, without.
(TIFF)
Figure S6.  Residues shown in Movie S8 as stick models.
(TIFF)
Figure S7.  Residues shown in Movie S9 as stick models,
these are the same residues as Figure S6.
(TIFF)
Movie S1.  Example 4 Nanosecond Simulation With SMX.
Simulation with SMX for trajectory 5. This shows a single MD
simulation as a representation of the entire MD analyzed for
each trajectory set overall with SMX present. All atoms are
shown as wire models. The pHLA is held positionally
restrained, however amino acid side chains have free
movement.
(AVI)
Movie S2.  Example 4 Nanosecond Simulation Without
SMX. Simulation without SMX for trajectory trajn_5. These
show single MD simulations as a representation of the entire
MD analyzed for each trajectory set overall. All atoms are
shown as wire models. The pHLA is held positionally
restrained, however amino acid side chains have free
movement.
(AVI)
Movie S3.  Principle Component 1 Primary Motion. Movie of
Vector 1, or Principal component 1 (PC1). The trajectory was
filtered using Gromacs tools to only show movements along the
primary eigenvector produced from covariance analysis and
using the TCR coordinates. Vector analysis produces vectors
ordered according to descending overall contribution to the
total energy found in the MD simulations for the analyzed
protein or portion of protein involved, which are also plotted
energy wise in Figure 5,6 and Figure S6. The first 3 vectors
produced represent 90, or 90.1% of all energy and overall
motion.
(AVI)
Movie S4.  Principle Component 2 Primary Motion. Movie of
Vector 2, or Principal component 2 (PC2). The trajectory was
filtered using Gromacs tools to only show movements along the
secondary eigenvector produced from covariance analysis and
using the TCR coordinates.
(AVI)
Movie S5.  Principle Component 3 Primary Motion. Movie of
Vector 3, or Principal component 3 (PC3). The trajectory was
filtered using Gromacs tools to only show movements along the
tertiary eigenvector produced from covariance analysis and
using the TCR coordinates.
(AVI)
Movie S6.  Filtered Random Motion Removal for Example
SMX Containing Trajectory. Filtered trajectory for simulation
shown in movie 1. Filtered trajectories use averaging of motion
with N=3 using the Gromacs filter (cosine(π*time frames/N) to
remove random movements caused by oscillation or random
solvent effects. Resultant motions are non-random and
associated with overall domain changes in the TCR as it moves
from pHLA bound to free in solvent across the simulation.
These motions are also observed from PCA analysis and
simple RMSD or RMSF analysis in static representations.
Trajectory 5 was used to produce movie.
(AVI)
Movie S7.  Filtered Random Motion Removal for Example
Trajectory. Filtered trajectory for simulation shown in movie 2.
Filtered trajectories use averaging of motion with N=3 using the
Gromacs filter (cosine(π*time frames/N) to remove random
movements caused by oscillation or random solvent effects.
Resultant motions are non-random and associated with overall
domain changes in the TCR as it moves from pHLA bound to
free in solvent across the simulation. These motions are also
observed from PCA analysis and simple RMSD or RMSF
analysis in static representations. Trajectory n5 was used to
produce movie.
(AVI)
Movie S8.  Example Trajectories Showing Important
Residues in CDR2β Switch With SMX. SMX effects on the
Vβ20-1 domain. Residues shown as sticks are labeled in the
static image, Figure S6. Differences are observed in the initial
structures between Movies S8 and S9. Overall, two amino
acids, ASP 64 and LYS 65 effect a larger translated hydrogen
bonding along the outer portions of the separate β loops,
bridging between loops. The long range effects shown are
seen to culminate in the constant loop region from β220-230,
and also the position of the distal end of the CDR1-2β spanning
loop. This shows how two single hydrogen bonds can be
amplified and transmit a much larger signal across a protein
from a ligand. SMX shown as wire model.
(AVI)
Movie S9.  Example Trajectories Showing Important
Residues in CDR2β Switch Without SMX. The Vβ20-1
domain without SMX. Residues shown as sticks are labeled in
the static image Figures S6 and S7. Differences are observed
in the initial structures, and the entire pHLA dissociation can be
compared to see how long range differences are transmitted on
the outer surface of the TCR. Cover of movie 9, Figure S7, are
same residues labeled in Figure S6, held in different positions
without SMX.
(AVI)
Table S1.  Standard error for all distance measurements
shown in Figure 5, listed as individual atom pairs. Atoms
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used vary between residue and are reflected in increases
distance from Cα, as shown by residue β65 (LYS terminal N)
Vs. α46 (GLU back bone O) in standard error averaged across
all trajectories.
(XLS)
Table S2.  Pearsons linear correlation coefficient
calculated for atom linear movement against the first three
PC of the entire TCR. Labels are atom pair and V, vector
used, followed by calculated Pearsons r-value from mean
averaged linear distances from all trajectories. These indicate
differences in correlated motions, between SMX or no SMX
TCR, and are the same atom pairs shown in Figure 6B.
(XLS)
Table S3.  Selected hydrogen bonds found by tabulating
all trajectories, with or without SMX. All hydrogen bonds are
shown for TCR and HLA or TCR and peptide, with number of
total hydrogen bonds shown. These bonds oscillate and as
shown in Figure S6, only 15 without and 12 with on average
are present per the first 200-300 picoseconds. Select hydrogen
bonds for loops in the Vα, Alpha loops, or Vβ, Beta loops, Beta
1-2 bridge, and Alpha 1-2 Bridge refer to loops connecting the
CDR1 and CDR2 loops, and are upper facing the constant
domain of the TCR. For these hydrogen bonds between other
residues in the TCR are listed, based on possible correlation
with TCR structural change, and selected based on visual
inspection of starting structure as a means to check suspected
changes. Not all bonds found in the TCR are listed. **, bonds
which show high degree of oscillation between frames and
trajectories. BB, back bone interaction. Not all backbone
interactions are indicated.
(XLS)
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